Apremilast Therapeutic Cheat Sheet
Apremilast (OTEZLA®) is a twice daily oral medication that is FDA approved for adults with plaque psoriasis, psoriatic arthritis and oral ulcers associated with Behçet’s Disease.1 This drug is being extended as an off-label treatment to target inflammation in a number of different conditions. This Therapeutic Cheat Sheet will focus on apremilast and its applications for different dermatologica …
Apremilast (OTEZLA®) is a twice daily oral medication that is FDA approved for adults with plaque psoriasis, psoriatic arthritis and oral ulcers associated with Behçet’s Disease.1 This drug is being extended as an off-label treatment to target inflammation in a number of different conditions. This Therapeutic Cheat Sheet will focus on apremilast and its applications for different dermatologica … 
Bustle recently posted an article on tricks to strengthen dry and brittle nails. How should dermatology clinicians counsel their patients who have dry, brittle nails? What nail conditions are sometimes misdiagnosed as dry, brittle nails?
For expert advice, I reached out to Molly Hinshaw, MD, professor of dermatology, section chief of dermatopathology and director of the nail clinic at the U … 
The August issue of the Journal of Drugs in Dermatology (JDD) focuses on Psoriasis and features mix of original articles, editorials, and case reports. Among many of the topics explored in this issue are treatment of scalp psoriasis, nail psoriasis, respiratory tract infections in patients using biologics for hidradenitis suppurativa, classification of actinic keratosis, lichen planus pigmentosus … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Molly Hinshaw (who is board certified in Dermatology and Dermatopathology, and directs the Nail Clinic at UWHealth in Madison, WI) about nail biopsies. Watch as she offers advice to her fellow dermatologists on preparing themselves (as well as their staff and patients) before this procedure … 
The February 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from psoriasis and actinic keratoses to artificial intelligence in dermatology and disparities in telemedicine satisfaction, we share this month’s issue highlights straight from the JDD Editor’s desk:
Early Response is Associ …